Clinical Trials Browser

Phase 2 × LY2510924 × Genitourinary × Clear all

NCT01391130 2019-07-23

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Phase 2 Terminated

110 enrolled 14 charts

Clear-cell metastatic renal cell carcinoma, Neoplasm Metastasis, Neoplasms